TABLE 5.
Characterization of CBR-2092 single-step mutants derived from rifampin-resistant strains
| Strain | Parent strain | Parent strain genotype | Selection concn (μg/ml) | Ending strain genotype | CBR-2092 broth microdilution MIC (μg/ml) |
|---|---|---|---|---|---|
| CB1522 | CB1244 | rpoBH481Y | NAa | NA | 0.25 |
| CB1523 | CB1522 | rpoBH481Y | 0.25 | rpoBH481YgyrAA26V | 1 |
| CB1524 | CB1522 | rpoBH481Y | 0.25 | rpoBH481YgyrAG773V | 2 |
| CB1416 | CB370 | rpoBH481Y | 0.1 | rpoBH481YgyrAL795S | 0.5 |
| CB1417 | CB370 | rpoBH481Y | 0.1 | rpoBH481YgyrAG532V | 0.5 |
| CB1418 | CB370 | rpoBH481Y | 0.1 | rpoBH481YgyrAD705N | 0.5 |
| CB1419 | CB370 | rpoBH481Y | 0.1 | rpoBH481YgyrAG572D | 1 |
| CB1420 | CB370 | rpoBH481Y | 0.1 | rpoBH481YgyrAG584V | 0.5 |
| CB1326 | CB370 | rpoBH481Y | 0.2 | rpoBH481YgyrAS784F | 0.5 |
| CB1327 | CB370 | rpoBH481Y | 0.2 | rpoBH481Y gyrAS84L | 0.5 |
| CB1421 | CB809 | rpoBH481YparCS80F | 0.18 | rpoBH481YparCS80FgyrAS84L | 1 |
| CB1430 | CB812 | rpoBH481YgyrAS84L | 0.18 | rpoBH481YparEE474KgyrAS84L | 16 |
| CB1333 | CB815 | rpoBH481YparCS80FgyrAS84L | 0.8 | rpoBH481YparCS80FparEL517FgyrAS84L | 16 |
| CB1334 | CB815 | rpoBH481YparCS80FgyrAS84L | 0.8 | rpoBH481YparCS80F, Q27HgyrAS84L | 8 |
| CB1335 | CB815 | rpoBH481YparCS80FgyrAS84L | 0.8 | rpoBH481YparCS80FparEE474QgyrAS84L | >16 |
| CB1353 | CB815 | rpoBH481YparCS80FgyrAS84L | 0.53 | rpoBH481YparCS80FparEV458GgyrAS84L | 16 |
| CB1354 | CB815 | rpoBH481YparCS80FgyrAS84L | 0.53 | rpoBH481YparCS80FparER455HgyrAS84L | 16 |
NA, not applicable.